Evelo Biosciences Inc KOL Event - Corporate Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the Evelo Biosciences event, the future and no regrets treatment for all stages of psoriasis and broader inflammation disease. Please be advised today's conference may be recorded.
I would now like to hand the conference over to your first speaker today, Kendra Sweeney, Head of Investor Relations and Capital Markets at Evelo Biosciences. Please standby.
Before we begin, I would like to remind everyone that statements made during this conference call that do not relate to matters of historical fact, including statements about our objectives and anticipated clinical milestones, the impact of any of our product candidates and the timing and results of any clinical studies should be considered forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are intended to be subject to the safe harbor protection provided by the Reform Act. Actual
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |